Results 71 to 80 of about 53,534 (265)

Percutaneous Deployment of the Sinus‐SuperFlex‐DS Stent for Hybrid Stage I Palliation in Neonates Weighing ≤ 2.5 kg: A Multicenter Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Hybrid stage I palliation (HS1P) has developed as an alternative to the Norwood stage I palliation for neonates with hypoplastic left heart and related left‐sided obstructive lesions. HS1P is currently used in various clinical settings, such as single ventricle palliation, bridge to decision, bridge to biventricular repair, or ...
Johanna Hummel, Jochen Grohmann, Katarzyna Gendera, Götz Müller, Harald Bertram, Matthias Sigler, Dietmar Schranz, Christian Jux, Markus Khalil   +8 more
wiley   +1 more source

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

, 2007
Although rare, stent thrombosis remains a severe complication after stent implantation owing to its high morbidity and mortality. Since the introduction of drug-eluting stents (DES), most interventional centers have noted stent thrombosis up to 3 years ...
Joner, M, Lüscher, Thomas F, Nakazawa, Gaku, Tanner, Felix C, Virmani, Renu, Eberli, F R, Steffel, Jan, Lüscher, T F, Joner, Michael, Steffel, J, Eberli, Franz R, Tanner, F C, Nakazawa, G, Virmani, R   +13 more
core   +1 more source

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention

Clinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 and CYP3A4 contribute to clopidogrel bioactivation. CYP2C19 no‐function alleles diminish clopidogrel's antiplatelet effects and clinical effectiveness. Coadministration of either a CYP2C19 or a CYP3A4 inhibitor may also reduce clopidogrel's antiplatelet effects and lead to phenoconversion in patients without a CYP2C19 no‐function allele (normal/
Danwei Shao, Jean G. Malavé, Joseph S. Rossi, Francesco Franchi, Ellen C. Keeley, Dominick J. Angiolillo, George A. Stouffer, Larisa H. Cavallari, Craig R. Lee   +8 more
wiley   +1 more source

Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation

, 2010
Impaired response to antiplatelet therapy with acetylsalicylic acid (ASA) and clopidogrel (CLO) has been associated with an increased risk of stent thrombosis and ischemic events after coronary stent implantation.
Hess, Otto M, Windecker, Stephan, Togni, Mario, Billinger, Michael, Eshtehardi, Parham, Garachemani, Ali, Cook, Stéphane, Wenaweser, Peter, Meier, Bernhard   +8 more
core   +1 more source

From Negative Duplex to Phlegmasia in Minutes: Bedside POCUS Identifies Rapid Thrombosis Unmasking Underlying May–Thurner Syndrome

Journal of Clinical Ultrasound, EarlyView.
Point‐of‐care‐ultrasound revealed an evolving acute noncompressible deep vein thrombosis (asterisks) in the left lower extremity veins (right panel) that was not evident on duplex ultrasound 14 min prior (left panel; asterisks demonstrate compressed veins). The patient was treated emergently and found to have May–Thurner syndrome.
Anthony Unger
wiley   +1 more source

Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?

SA Heart Journal, 2017
Stent thrombosis is a catastrophic complication of percutaneous coronary intervention (PCI) and is associated with a mortality of 25 to 40%. The perception that stent thrombosis is very low in all patients has resulted in a lack of adherence to ...
John Benjamin
doaj   +1 more source

Postoperative Weight Gain, Due to Fluid Retention After Ovarian Cancer Surgery—How Much Is too Much?

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Postoperative complications after cytoreductive surgery in ovarian cancer patients are associated with impaired survival. Here, we investigated the association between postoperative weight gain due to fluid retention and the development of complications and anastomotic leakage (AL).
Eva K. Egger, Melisa Delen, Hanno Matthaei, Laura Tascon Padron, Carolin Schröder, Milka Marinova, Dominique Koensgen, Alexander Mustea   +7 more
wiley   +1 more source

The hypercoagulable profile of patients with stent thrombosis

, 2015
Objective Coronary stent thrombosis is a devastating complication after percutaneous coronary intervention (PCI). The mechanisms underlying stent thrombosis are multifactorial.
Spronk, H. M. H., Loeffen, R., Hackeng, C. M., van Oerle, R., ten Berg, J. M., ten Cate, H., Godschalk, T. C.   +6 more
core   +1 more source

Hospital Volume and Post‐Hepatectomy Liver Failure After Major Hepatectomy

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background Post‐hepatectomy liver failure (PHLF) following major hepatectomy (MH) increases the risk of morbidity and death. The relationship between institutional MH volume, PHLF, and outcomes is not well characterized. Methods Adults undergoing MH from 2014 to 2021 in the ACS NSQIP hepatectomy‐targeted database were included.
Xane D. Peters, Brian C. Brajcich, Bona Ko, Catherine Valukas, Lauren M. Janczewski, Clifford Y. Ko, Ryan P. Merkow, Henry A. Pitt, David J. Bentrem   +8 more
wiley   +1 more source

Acute ST-Elevation Myocardial Infarction after Coronary Stent Fracture

Journal of Tehran University Heart Center, 2016
The invention of the drug-eluting stent (DES) has brought about revolutionary changes in the field of interventional cardiology. In the DES era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged.
Abbasali Rafighdust, Ali Eshraghi
doaj